loadpatents
name:-0.080350160598755
name:-0.082891941070557
name:-0.020668029785156
Schlom; Jeffrey Patent Filings

Schlom; Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schlom; Jeffrey.The latest application filed is for "brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use".

Company Profile
20.86.73
  • Schlom; Jeffrey - Potomac MD
  • Schlom; Jeffrey - Potamac MD
  • Schlom; Jeffrey - Vienna VA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, and their use
Grant 11,357,839 - Schlom , et al. June 14, 2
2022-06-14
Development of agonist epitopes of the human papillomavirus
Grant 11,311,613 - Schlom , et al. April 26, 2
2022-04-26
Brachyury Deletion Mutants, Non-yeast Vectors Encoding Brachyury Deletion Mutants, And Their Use
App 20210380652 - Schlom; Jeffrey ;   et al.
2021-12-09
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
Grant 11,155,588 - Schlom , et al. October 26, 2
2021-10-26
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use
App 20210253656 - Schlom; Jeffrey ;   et al.
2021-08-19
Modified yeast-brachyury immunotherapeutic compositions
Grant 11,065,313 - King , et al. July 20, 2
2021-07-20
Yeast-MUC1 immunotherapeutic compositions and uses thereof
Grant 11,065,318 - Franzusoff , et al. July 20, 2
2021-07-20
Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use
Grant 11,034,740 - Schlom , et al. June 15, 2
2021-06-15
Combination Immunotherapy Compositions Against Cancer and Methods
App 20210113677 - Hodge; James ;   et al.
2021-04-22
Yeast-brachyury Immunotherapeutic Compositions
App 20210106666 - Palena; Claudia ;   et al.
2021-04-15
Combination Immunotherapy Compositions Against Cancer and Methods
App 20210069308 - Hodge; James ;   et al.
2021-03-11
Combination immunotherapy compositions against cancer and methods
Grant 10,874,729 - Hodge , et al. December 29, 2
2020-12-29
Brachyury Deletion Mutants, Non-yeast Vectors Encoding Brachyury Deletion Mutants, And Their Use
App 20200181215 - Schlom; Jeffrey ;   et al.
2020-06-11
Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis
App 20200140567 - Schlom; Jeffrey ;   et al.
2020-05-07
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use
App 20200109181 - Schlom; Jeffrey ;   et al.
2020-04-09
Combination Immunotherapy Compositions Against Cancer and Methods
App 20200069784 - Hodge; James ;   et al.
2020-03-05
Yeast-based Immunotherapy For Chordoma
App 20200046818 - RODELL; Timothy C. ;   et al.
2020-02-13
Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use
Grant 10,550,164 - Schlom , et al. Fe
2020-02-04
Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein
Grant 10,508,141 - Schlom , et al. Dec
2019-12-17
Yeast-based immunotherapy for Chordoma
Grant 10,507,235 - Rodell , et al. Dec
2019-12-17
Yeast-brachyury Immunotherapeutic Compositions
App 20190374624 - Palena; Claudia ;   et al.
2019-12-12
Development Of Agonist Epitopes Of The Human Papillomavirus
App 20190314479 - Schlom; Jeffrey ;   et al.
2019-10-17
Combination immunotherapy compositions against cancer and methods
Grant 10,383,924 - Hodge , et al. A
2019-08-20
Yeast-muc1 Immunotherapeutic Compositions And Uses Thereof
App 20190231859 - Franzusoff; Alex ;   et al.
2019-08-01
Yeast-brachyury immunotherapeutic compositions
Grant 10,363,294 - Palena , et al.
2019-07-30
Brachyury Protein, Non-poxvirus Non-yeast Vectors Encoding Brachyury Protein, And Their Use
App 20190046619 - Schlom; Jeffrey ;   et al.
2019-02-14
Yeast-MUC1 immunotherapeutic compositions and uses thereof
Grant 10,188,714 - Franzusoff , et al. Ja
2019-01-29
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use
App 20190002513 - Schlom; Jeffrey ;   et al.
2019-01-03
Native and agonist CTL epitopes of the MUC1 tumor antigen
Grant 10,138,271 - Schlom , et al. Nov
2018-11-27
Brachyury Deletion Mutants, Non-yeast Vectors Encoding Brachyury Deletion Mutants, And Their Use
App 20180222951 - Schlom; Jeffrey ;   et al.
2018-08-09
Modified Yeast-brachyury Immunotherapeutic Compositions
App 20180214525 - KING; Thomas H. ;   et al.
2018-08-02
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
Grant 10,035,832 - Schlom , et al. July 31, 2
2018-07-31
Biomarkers for prostate cancer and methods for their detection
Grant 9,804,163 - Gildersleeve , et al. October 31, 2
2017-10-31
Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis
App 20170306042 - Schlom; Jeffrey ;   et al.
2017-10-26
Yeast-brachyury Immunotherapeutic Compositions
App 20170246276 - Palena; Claudia ;   et al.
2017-08-31
Yeast-muc1 Immunotherapeutic Compositions And Uses Thereof
App 20170224794 - Franzusoff; Alex ;   et al.
2017-08-10
Soluble CD27 (sCD27) and the use thereof
Grant 9,725,494 - Schlom , et al. August 8, 2
2017-08-08
Yeast-brachyury immunotherapeutic compositions
Grant 9,623,097 - Palena , et al. April 18, 2
2017-04-18
Biomarkers For Prostate Cancer And Methods For Their Detection
App 20170052185 - Gildersleeve; Jeffrey ;   et al.
2017-02-23
Yeast-MUC1 immunotherapeutic compositions and uses thereof
Grant 9,533,031 - Franzusoff , et al. January 3, 2
2017-01-03
Yeast-based Immunotherapy For Chordoma
App 20160271238 - RODELL; Timothy C. ;   et al.
2016-09-22
Hla-a24 Agonist Epitopes Of Muc1-c Oncoprotein And Compositions And Methods Of Use
App 20160251406 - SCHLOM; Jeffrey ;   et al.
2016-09-01
Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1
Grant 9,370,559 - Schlom , et al. June 21, 2
2016-06-21
Yeast-brachyury Immunotherapeutic Compositions
App 20160106824 - Palena; Claudia ;   et al.
2016-04-21
Yeast-Brachyury immunotherapeutic compositions
Grant 9,198,941 - Palena , et al. December 1, 2
2015-12-01
Immunogenic peptides and methods of use
Grant 9,175,057 - Schlom , et al. November 3, 2
2015-11-03
Brachyury Protein, Non-poxvirus Non-yeast Vectors Encoding Brachyury Protein, And Their Use
App 20150224181 - Schlom; Jeffrey ;   et al.
2015-08-13
Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1
Grant 8,957,192 - Schlom , et al. February 17, 2
2015-02-17
System for treating and preventing breast cancer
Grant 8,933,041 - Panicali , et al. January 13, 2
2015-01-13
Native And Agonist Ctl Epitopes Of The Muc1 Tumor Antigen
App 20140363495 - Schlom; Jeffrey ;   et al.
2014-12-11
Custom vectors for treating and preventing pancreatic cancer
Grant 8,901,093 - Panicali , et al. December 2, 2
2014-12-02
Soluble Cd27 (scd27) And The Use Thereof
App 20140341931 - Schlom; Jeffrey ;   et al.
2014-11-20
Mutated ras peptides for generation of CD8.sup.+ cytotoxic T lymphocytes
Grant 8,883,448 - Schlom , et al. November 11, 2
2014-11-11
Immunogenic Epitopes Of Ngep Antigen
App 20140287029 - Schlom; Jeffrey ;   et al.
2014-09-25
Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors
Grant 8,835,167 - Kashmiri , et al. September 16, 2
2014-09-16
Framework residue substituted humanized COL-1 antibodies and their use
Grant 8,828,717 - Kashmiri , et al. September 9, 2
2014-09-09
Immunogenic epitopes of NGEP antigen
Grant 8,748,390 - Schlom , et al. June 10, 2
2014-06-10
Brachyury Polypeptides And Methods For Use
App 20140135488 - Schlom; Jeffrey ;   et al.
2014-05-15
Yeast-brachyury Immunotherapeutic Compositions
App 20140004135 - Palena; Claudia ;   et al.
2014-01-02
Brachyury polypeptides and methods for use
Grant 8,613,933 - Schlom , et al. December 24, 2
2013-12-24
Humanized Anti-tag 72 Cc49 For Diagnosis And Therapy Of Human Tumors
App 20130337559 - Kashmiri; Syed V.S. ;   et al.
2013-12-19
Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
Grant 8,609,395 - Schlom , et al. December 17, 2
2013-12-17
Yeast-muc1 Immunotherapeutic Compositions And Uses Thereof
App 20130315941 - Franzusoff; Alex ;   et al.
2013-11-28
Human Cytotoxic T-lymphocyte Epitope And Its Agonist Epitope From The Non-variable Number Of Tandem Repeat Sequence Of Muc-1
App 20130309260 - Schlom; Jeffrey ;   et al.
2013-11-21
Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies
Grant 8,535,890 - Kashmiri , et al. September 17, 2
2013-09-17
Biomarkers For Prostate Cancer And Methods For Their Detection
App 20130156813 - Gildersleeve; Jeffrey ;   et al.
2013-06-20
Brachyury Polypeptides And Methods For Use
App 20120230948 - Schlom; Jeffrey ;   et al.
2012-09-13
Agonist And Antagonist Peptides Of Carcinoembryonic Antigen (cea)
App 20120149102 - Schlom; Jeffrey ;   et al.
2012-06-14
Brachyury polypeptides and methods for use
Grant 8,188,214 - Schlom , et al. May 29, 2
2012-05-29
Methods of stimulating an immune response against prostate specific antigen
Grant 8,178,508 - Schlom , et al. May 15, 2
2012-05-15
Combination Immunotherapy Compositions Against Cancer And Methods
App 20120107347 - Hodge; James ;   et al.
2012-05-03
Immunogenic Epitopes Of Ngep Antigen
App 20120052116 - Schlom; Jeffrey ;   et al.
2012-03-01
Human Cytotoxic T-lymphocyte Epitope And Its Agonist Epitope From The Non-variable Number Of Tandem Repeat Sequence Of Muc-1
App 20110319869 - Schlom; Jeffrey ;   et al.
2011-12-29
Variants of humanized anti-carcinoma MAb CC49
Grant 8,029,788 - Kashmiri , et al. October 4, 2
2011-10-04
Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1
Grant 7,999,071 - Schlom , et al. August 16, 2
2011-08-16
Immunogenic Peptides And Methods Of Use
App 20110165117 - Schlom; Jeffrey ;   et al.
2011-07-07
Methods To Determine Immunogenicity Of Humanized Anti-tag 72 Cc49 Antibodies
App 20110159525 - Kashmiri; Syed V.S. ;   et al.
2011-06-30
Methods Of Stimulating An Immune Response Against Prostate Specific Antigen
App 20110091498 - Schlom; Jeffrey ;   et al.
2011-04-21
Nucleic acids encoding humanized anti-tag 72 CC49 antbodies
Grant 7,919,607 - Kashmiri , et al. April 5, 2
2011-04-05
Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49
Grant 7,915,396 - Kashmiri , et al. March 29, 2
2011-03-29
Immunogenic peptides and methods of use
Grant 7,910,692 - Schlom , et al. March 22, 2
2011-03-22
Framework Residue Substituted Humanized Col-1 Antibodies And Their Use
App 20110053264 - KASHMIRI; SYED ;   et al.
2011-03-03
Methods of stimulating an immune response against prostate specific antigen
Grant 7,871,986 - Schlom , et al. January 18, 2
2011-01-18
Framework residue substituted humanized COL-1 antibodies and their use
Grant 7,855,276 - Kasmiri , et al. December 21, 2
2010-12-21
VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49
App 20100303720 - Kashmiri; Syed V.S. ;   et al.
2010-12-02
Agonist And Antagonist Peptides Of Carcinoembryonic Antigen (cea)
App 20100209386 - Schlom; Jeffrey ;   et al.
2010-08-19
Recombinant vector expressing multiple costimulatory molecules and uses thereof
Grant 7,771,715 - Schlom , et al. August 10, 2
2010-08-10
Variants of humanized anti-carcinoma MAb CC49
Grant 7,763,719 - Kashmiri , et al. July 27, 2
2010-07-27
Compositions And Methods For Chitosan Enhanced Immune Response
App 20100150960 - Schlom; Jeffrey ;   et al.
2010-06-17
Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides
Grant 7,723,096 - Schlom , et al. May 25, 2
2010-05-25
Mutated ras peptides for generation of CD8.sup.+Cytotoxic T lymphocytes
Grant 7,709,002 - Schlom , et al. May 4, 2
2010-05-04
Mutated Ras Peptides For Generation Of Cd8+ Cytotoxic T Lymphocytes
App 20100074945 - Schlom; Jeffrey ;   et al.
2010-03-25
Brachyury Polypeptides And Methods For Use
App 20100055121 - Schlom; Jeffrey ;   et al.
2010-03-04
Method of enhancing a targeted immune response against tumors
Grant 7,662,395 - Schlom , et al. February 16, 2
2010-02-16
Humanized Anti-tag 72 Cc49 For Diagnosis And Therapy Of Human Tumors
App 20090317903 - Kashmiri; Syed V.S. ;   et al.
2009-12-24
Minimally Immunogenic Variants Of Sdr-grafted Humanized Antibody Cc49 And Their Use
App 20090311780 - Kashmiri; Syed V.S. ;   et al.
2009-12-17
Methods Of Stimulating An Immune Response Against Prostate Specific Antigen
App 20090263425 - Schlom; Jeffrey ;   et al.
2009-10-22
Generation of immune response to prostate-specific antigen (PSA)
Grant 7,598,225 - Schlom , et al. October 6, 2
2009-10-06
Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use
Grant 7,589,181 - Kashmiri , et al. September 15, 2
2009-09-15
Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors
Grant 7,569,673 - Kashmiri , et al. August 4, 2
2009-08-04
Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides
Grant 7,547,773 - Schlom , et al. June 16, 2
2009-06-16
Recombinant vector expressing multiple costimulatory molecules and uses thereof
App 20090041804 - Schlom; Jeffrey ;   et al.
2009-02-12
Immunogenic Peptides And Methods Of Use
App 20090035266 - Schlom; Jeffrey ;   et al.
2009-02-05
Method Of Enhancing A Targeted Immune Response Against Tumors
App 20080279887 - Schlom; Jeffrey ;   et al.
2008-11-13
Framework Residue Substituted Humanized Col-1 Antibodies and Their Use
App 20080274055 - Kashmiri; Syed ;   et al.
2008-11-06
Recombinant pox virus for immunization against tumor-associated antigens
Grant 7,410,644 - Schlom , et al. August 12, 2
2008-08-12
Custom Vectors for Treating and Preventing Pancreatic Cancer
App 20080166367 - Panicali; Dennis L. ;   et al.
2008-07-10
Method of enhancing a targeted immune response against tumors
Grant 7,368,116 - Schlom , et al. May 6, 2
2008-05-06
Human Cytotoxic T-Lymphoctye Epitope and Its Agonist Eptiope From the Non-Variable Number of Tandem Repeat Sequence of Muc-1
App 20080063653 - Schlom; Jeffrey ;   et al.
2008-03-13
VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49
App 20080050810 - Kashmiri; Syed V.S. ;   et al.
2008-02-28
Variants of humanized anti-carcinoma monoclonal antibody CC49
Grant 7,256,004 - Kashmiri , et al. August 14, 2
2007-08-14
Peptide agonists of prostate-specific antigen and uses therefor
Grant 7,247,615 - Schlom , et al. July 24, 2
2007-07-24
System for treating and preventing breast cancer
App 20070110718 - Panicali; Dennis L. ;   et al.
2007-05-17
Prostate specific antigen oligo-epitope peptide
App 20070098691 - Schlom; Jeffrey ;   et al.
2007-05-03
Recombinant vector expressing multiple costimulatory molecules and uses thereof
Grant 7,211,432 - Schlom , et al. May 1, 2
2007-05-01
Carcinoembryonic antigen (CEA) peptides
App 20070048860 - Schlom; Jeffrey ;   et al.
2007-03-01
Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72
Grant 7,179,899 - Mezes , et al. February 20, 2
2007-02-20
Recombinant pox virus for immunization against MUC1 tumor-associated antigen
Grant 7,118,738 - Schlom , et al. October 10, 2
2006-10-10
Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors
App 20060165680 - Kashmiri; Syed V.S. ;   et al.
2006-07-27
Recombinant vector expressing multiple costimulatory molecules and uses thereof
Grant 6,969,609 - Schlom , et al. November 29, 2
2005-11-29
Prostate specific antigen oligo-epitope peptide
Grant 6,946,133 - Schlom , et al. September 20, 2
2005-09-20
Prostate specific antigen oligoepitope peptide
App 20050196806 - Schlom, Jeffrey ;   et al.
2005-09-08
Variants of humanized anti-carcinoma monoclonal antibody CC49
App 20050186202 - Kashmiri, Syed V.S. ;   et al.
2005-08-25
Enhanced immune response to an antigen by a composition of a recominant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
App 20050186180 - Schlom, Jeffrey ;   et al.
2005-08-25
Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
Grant 6,893,869 - Schlom , et al. May 17, 2
2005-05-17
Enhanced Immune Response To An Antigen By A Composition Of A Recombinant Virus Expressing The Antigen With A Recombinant Virus Expressing An Immunostimulatory Molecule
App 20050063993 - Schlom, Jeffrey ;   et al.
2005-03-24
Peptide agonists of prostate-specific antigen and uses therefor
App 20050054575 - Schlom, Jeffrey ;   et al.
2005-03-10
Variants of humanized anti carcinoma monoclonal antibody cc49
Grant 6,818,749 - Kashmiri , et al. November 16, 2
2004-11-16
Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
App 20040171796 - Schlom, Jeffrey ;   et al.
2004-09-02
Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
Grant 6,756,038 - Schlom , et al. June 29, 2
2004-06-29
Recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
App 20040091995 - Schlom, Jeffrey ;   et al.
2004-05-13
Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72
App 20030165498 - Mezes, Peter S. ;   et al.
2003-09-04
Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
Grant 6,548,068 - Schlom , et al. April 15, 2
2003-04-15
Recombinant pox virus for immunization against MUC1 tumor-associated antigen
App 20030021770 - Schlom, Jeffrey ;   et al.
2003-01-30
Recombinant pox virus for immunization against tumor-associated antigens
App 20030003079 - Schlom, Jeffrey ;   et al.
2003-01-02
Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains
Grant 6,495,137 - Mezes , et al. December 17, 2
2002-12-17
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
Grant 6,319,496 - Panicali , et al. November 20, 2
2001-11-20
Generation of immune responses to prostate-specific antigen (PSA)
Grant 6,165,460 - Schlom , et al. December 26, 2
2000-12-26
Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
Grant 6,045,802 - Schlom , et al. April 4, 2
2000-04-04
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
Grant 6,001,349 - Panicali , et al. December 14, 1
1999-12-14
Family of high affinity, modified antibodies for cancer treatment
Grant 5,993,813 - Mezes , et al. November 30, 1
1999-11-30
Production of a single-gene-encoded immunoglobulin
Grant 5,892,019 - Schlom , et al. April 6, 1
1999-04-06
Recombinant virus expressing human carcinoembryonic antigen and methods of use thereof
Grant 5,698,530 - Schlom , et al. December 16, 1
1997-12-16
Family of anti-carcinoembryonic antigen chimeric antibodies
Grant 5,472,693 - Gourlie , et al. December 5, 1
1995-12-05
Monoclonal antibody (D612) having selective reactivity for gastrointestinal caricinomas and method for employing the same
Grant 5,183,756 - Schlom February 2, 1
1993-02-02
Monoclonal antibodies reactive with human breast cancer
Grant 4,612,282 - Schlom , et al. * September 16, 1
1986-09-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed